Methylcarbamyl PAF C-8
Product Specifications
Target
C-Myc, p38 MAPK
Related Pathways
MAPK, Cell Cycle/Checkpoint
Bioactivity
Methylcarbamyl PAF C-8 is resistant to degradation by PAF-AH and has a half-life of over 100 minutes in platelet-poor plasma, exhibiting platelet aggregation activity. In NRK-49 cells overexpressing PAF receptor, it induces the expression of c-myc, c-fos, and activates mitogen-activated protein kinase (MAPK) . Furthermore, Methylcarbamyl PAF C-8 can induce G1 phase cell cycle arrest. This compound shows potential for research in cardiovascular and anti-cancer applications.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Syndecan 1 (SDC1) Mouse Monoclonal Antibody [Clone ID: OTI10D10]](https://cdn.genprice.uk/products/937/68dd18bc061270361e9090d2/imageurl/cf813799.webp)
CF813799 100 µg
Syndecan 1 (SDC1) Mouse Monoclonal Antibody [Clone ID: OTI10D10]
Sign In for Pricing
View Details 
TRC-T887910-50MG 50 mg
(3Alpha,5Beta,7Alpha,12Alpha)-3,7,12-Trihydroxy-cholest-24-en-26-oic Acid Ethyl Ester
Sign In for Pricing
View Details 
LC426693 20 µg
FLIP (CFLAR) (NM_001127183) Human Over-expression Lysate
Sign In for Pricing
View Details